Back to News
Market Impact: 0.28
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a securities class action lawsuit has been filed against Replimune Group (NASDAQ: REPL) and certain company officers. The announcement creates a legal overhang for the biotech company, though the release provides no allegations, damages, class period, or other financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
REPL-0.80
More News
- Paraguay raids ex-president’s home: Why a bank crash brought down Pena
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Why is Nvidia’s Jensen Huang at the centre of a US-China spy scandal?
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- What Jensen Huang's affair with an accused Chinese spy means for Nvidia stock
- Nvidia stock falls 5% as scrutiny turns to Jensen Huang’s relationship with alleged Chinese spy